Target Professions: DO, MD
Credits Available: 3.0 AMA PRA Category 1 Credits

New data regarding the use of anti-vascular endothelial growth factor (VEGF) prophylaxis in patients with moderate to severe nonproliferative diabetic retinopathy without diabetic macular edema underscore the need for an evidence-based shift to proactive diabetic retinopathy (DR) treatment (rather than “watch and wait”). Guideline recommendations do not reflect the available treatments, and strategies to reduce anti-VEGF treatment burden (eg, treat-and-extend dosing, high-dose and novel agents, and novel products) continue to evolve and emerge, challenging clinicians to stay current and highlighting the need for individualized treatment and shared decision-making in DR treatment.

This activity provides guidance for treatment of DR/diabetic macular edema (DME) with anti-VEGF agents, strategies to reduce anti-VEGF treatment burden (eg, treat-and-extend dosing, high-dose and novel agents, and novel products), and highlights the need for individualized treatment and shared decision-making in DR treatment.


CME/CE Accreditation Information

Itinerary

Module 1 - Treatment Options for Nonproliferative Diabetic Retinopathy

Explore treatment options for a patient with nonproliferative diabetic retinopathy (NPDR) and provide strategies for an optimal outcome

Module 2 - Treatment Options for Proliferative Diabetic Retinopathy-Diabetic Macular Edema

Explore options for a patient with PDR-DME and provide strategies for an optimal outcome.

Evaluating Treatment Options for Patients New to Your Practice

This Group Challenge will explore how you can improve your practice in welcoming new patients to your clinic. Treatment selection to maximize patients’ comfort and adherence will be considered.

Management Strategies to Treat Diabetic Retinopathy in Patients with Diabetes: Steps to Early Treatment and Consistent Care

In the live group discussion, the CME program content will be reviewed and discussed in a peer-to-peer setting, enabling participants to learn from their colleagues about treatment strategies to address diabetic retinopathy in their patients with diabetes.

Optimal Management of Diabetic Retinopathy: My Action Plan

Please share how you will manage new patients with diabetic retinopathy/diabetic macular edema in your practice.

Curriculum is Currently Closed

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings

Completed Groups

Puneet Braich, MD
Clinical Instructor
Completed
NM
Nitish Mehta, MD
Assistant Professor
Completed
Maxwell Stem, MD
Associate Vitreoretinal Surgeon
Completed
Jayanth Sridhar, MD
Assistant Professor of Clinical Ophthalmology
Completed
Fadi Nasrallah, MD
Physician
Completed
SP
SHIL PATEL, MD
PARTNER VITREORETINAL SPECIALIST
Completed
Sarwar Zahid, MD
Completed
PP
Pradeep Prasad, MD, MBA
Associate Professor of Ophthalmology
Completed
Michael Klufas, MD
Associate Professor
Completed
SP
Sarju Patel, MD MPH MSc
Attending Physician
Completed
Michael Klufas, MD
Associate Professor
Completed